These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3886410)

  • 21. Modulation of binding and bioactivity of insulin by anti-insulin antibody: relation to possible role of receptor self-aggregation in hormone action.
    Shechter Y; Chang KJ; Jacobs S; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2720-4. PubMed ID: 288060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of covalent insulin-receptor complexes on viable adipocytes by anti-insulin antibodies.
    Mucke P; Diaconescu C; Klotz G; Jørgensen P; Saunders D; Brandenburg D
    Biol Chem Hoppe Seyler; 1987 Feb; 368(2):85-92. PubMed ID: 3566917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin binding and action in antibody-induced diabetes in the rat.
    Kemmler W; Häring HU
    Diabetologia; 1982 Dec; 23(6):517-20. PubMed ID: 6759277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct demonstration that receptor crosslinking or aggregation is important in insulin action.
    Kahn CR; Baird KL; Jarrett DB; Flier JS
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4209-13. PubMed ID: 279910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of insulin-like actions of anti-insulin receptor antibodies. Effects on insulin binding, insulin degradation, and glycogen synthesis in isolated rat hepatocytes.
    Baldwin D; Terris S; Steiner DF
    J Biol Chem; 1980 May; 255(9):4028-34. PubMed ID: 6989831
    [No Abstract]   [Full Text] [Related]  

  • 26. Differences in the ability of anti-insulin antibody to aggregate monomeric ferritin-insulin occupied receptor sites on liver and adipocyte plasma membranes.
    Lyen KR; Smith RM; Jarett L
    Diabetes; 1983 Jul; 32(7):648-53. PubMed ID: 6345244
    [No Abstract]   [Full Text] [Related]  

  • 27. Binding of insulin to its receptor impairs recognition by monoclonal anti-insulin antibodies.
    Taylor SI; Schroer JA; Marcus-Samuels B; McElduff A; Bender TP
    Diabetes; 1984 Aug; 33(8):778-84. PubMed ID: 6378700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of the biologic activity of human serum bound insulin by potent insulin antisera.
    Antoniades HN; Simon JD
    Diabetes; 1972 Sep; 21(9):930-4. PubMed ID: 5055718
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for modulation of insulin action and degradation independently of insulin binding.
    Caro JF; Amatruda JM
    Am J Physiol; 1981 Mar; 240(3):E325-32. PubMed ID: 7011054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin--receptor interactions in adipose tissue cells: direct measurement and properties.
    Cuatrecasas P
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1264-8. PubMed ID: 5288373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiserum to liver insulin receptor hyperpolarizes rat muscle.
    Zierler K; Rogus EM
    Am J Physiol; 1983 Jan; 244(1):C58-60. PubMed ID: 6336908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregation of monomeric ferritin-insulin occupied receptor sites on liver plasma membranes caused by anti-insulin antibody.
    Lyen KR; Smith RM; Jarett L
    J Recept Res; 1981-1982; 2(5-6):523-30. PubMed ID: 6759649
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in the patching and capping of insulin receptors under the influence of hormonal imprinting.
    Kovács P; Török O; Csaba G
    Histochemistry; 1988; 90(3):241-4. PubMed ID: 3063696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On insulin I-131 metabolism in mice. Modifying effects of anti-insulin serum and of total insulin dosage.
    Beck LV; Zaharko DS; Roberts N; King C
    Diabetes; 1966 May; 15(5):336-41. PubMed ID: 5936461
    [No Abstract]   [Full Text] [Related]  

  • 35. A precipitating antibody to insulin.
    JONES VE; CUNLIFFE AC
    Nature; 1961 Oct; 192():136-8. PubMed ID: 14452345
    [No Abstract]   [Full Text] [Related]  

  • 36. Ligand-binding characteristics of feline insulin-binding immunoglobulin G.
    Suzuki T; Nishii N; Takashima S; Matsubara T; Iwasawa A; Takeuchi H; Tahara K; Hachisu T; Kitagawa H
    J Vet Med Sci; 2015 Nov; 77(11):1379-83. PubMed ID: 26062435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antibody-mediated crosslinking of insulin on its bioactivity and receptor binding.
    Keilacker H; Knospe S; Ziegler M; Whittaker J
    Exp Clin Endocrinol; 1985 Feb; 85(1):38-46. PubMed ID: 3886410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.
    Kahn CR; Baird K; Filier JS; Jarrett DB
    J Clin Invest; 1977 Nov; 60(5):1094-106. PubMed ID: 908753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin binding to isolated cells].
    Keilacker H; Ziegler M; Knospe S; Ziegler B; Besch W
    Acta Biol Med Ger; 1978; 37(4):601-11. PubMed ID: 735628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.
    King GL; Kahn CR; Rechler MM; Nissley SP
    J Clin Invest; 1980 Jul; 66(1):130-40. PubMed ID: 6995478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.